Enovis (ENOV) Capital Expenditures (2010 - 2026)
Enovis' (ENOV) quarterly Capital Expenditures came in at $43.9 million in Q3 2026, down 1.07% year-over-year from $44.4 million in Q3 2025, and down 16.87% quarter-over-quarter from $52.8 million in Q2 2026.
Analysis
Enovis (ENOV) Capital Expenditures (2010 - 2026) Analysis & Trends
Enovis (ENOV) has reported Capital Expenditures for 17 consecutive years, with $43.9 million the latest figure, recorded in Q3 2026.
- On a quarterly basis, Capital Expenditures fell 1.07% year-over-year to $43.9 million in Q3 2026; TTM through Jul 2026 was $206.4 million, a 7.52% increase from a year earlier, with the FY2025 full-year figure at $197.4 million, up 9.22% from the prior year.
- Capital Expenditures was $43.9 million for Q3 2026 at Enovis, down from $52.8 million in the prior quarter.
- Over five years, Capital Expenditures peaked at $56.3 million in Q4 2025 and troughed at $20.9 million in Q3 2022.
- A 5-year average of $39.0 million and a median of $38.2 million in 2024 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures decreased 27.91% in 2022 and soared 90.35% in 2024, its largest moves.
- Over 5 years, Capital Expenditures stood at $36.8 million in 2022, then decreased by 24.03% to $27.9 million in 2023, then soared by 90.35% to $53.2 million in 2024, then grew by 5.76% to $56.3 million in 2025, then dropped by 21.97% to $43.9 million in 2026.
- The last three Capital Expenditures figures came in at $43.9 million (Q3 2026), $52.8 million (Q2 2026), and $56.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 175.58 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | 112.60 Mn |
| 3 | Medtronic | 117.13 Bn | 108.31 Bn | 6.34 Bn | 503.00 Mn |
| 4 | Stryker | 104.67 Bn | 101.20 Bn | 4.50 Bn | 202.00 Mn |
| 5 | Boston Scientific | 64.48 Bn | 63.94 Bn | 3.85 Bn | 195.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 66.90 Mn |
| 7 | Alcon | 33.06 Bn | 31.61 Bn | 1.68 Bn | -96.00 Mn |
| 8 | Dexcom | 32.37 Bn | 30.43 Bn | 830.00 Mn | 84.70 Mn |
| 9 | Steris | 20.76 Bn | 20.28 Bn | 684.20 Mn | 87.50 Mn |
| 10 | Enovis | 1.07 Bn | 1.06 Bn | 359.25 Mn | 43.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 43.90 Mn |
| Apr 3, 2026 | 52.80 Mn |
| Dec 31, 2025 | 56.25 Mn |
| Oct 3, 2025 | 53.49 Mn |
| Jul 4, 2025 | 44.37 Mn |
| Apr 4, 2025 | 43.26 Mn |
| Dec 31, 2024 | 53.19 Mn |
| Sep 27, 2024 | 51.19 Mn |
| Jun 28, 2024 | 39.41 Mn |
| Mar 29, 2024 | 36.93 Mn |
| Dec 31, 2023 | 27.94 Mn |
| Sep 29, 2023 | 27.03 Mn |
| Jun 30, 2023 | 36.81 Mn |
| Mar 31, 2023 | 30.44 Mn |
| Dec 31, 2022 | 36.78 Mn |
| Sep 30, 2022 | 20.87 Mn |
| Jul 1, 2022 | 23.71 Mn |
| Apr 1, 2022 | 24.09 Mn |
| Dec 31, 2021 | 30.64 Mn |
| Oct 1, 2021 | 28.95 Mn |